{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:12Z","timestamp":1793890512783,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dysregulated IL-23\/IL-17 responses have been linked to psoriatic arthritis and other forms of spondyloarthritides (SpA). ROR\u03b3t, the key Thelper17 (Th17) cell transcriptional regulator, is also expressed by subsets of innate-like T cells, including invariant natural killer T (iNKT) and \u03b3\u03b4-T cells, but their contribution to SpA is still unclear. Here we describe the presence of particular ROR\u03b3t\n                    <jats:sup>+<\/jats:sup>\n                    T-bet\n                    <jats:sup>lo<\/jats:sup>\n                    PLZF\n                    <jats:sup>\u2212<\/jats:sup>\n                    iNKT and \u03b3\u03b4-hi T cell subsets in healthy peripheral blood. ROR\u03b3t\n                    <jats:sup>+<\/jats:sup>\n                    iNKT and \u03b3\u03b4-hi T cells show IL-23 mediated Th17-like immune responses and were clearly enriched within inflamed joints of SpA patients where they act as major IL-17 secretors. SpA derived iNKT and \u03b3\u03b4-T cells showed unique and Th17-skewed phenotype and gene expression profiles. Strikingly, ROR\u03b3t inhibition blocked \u03b3\u03b417 and iNKT17 cell function while selectively sparing IL-22\n                    <jats:sup>+<\/jats:sup>\n                    subsets. Overall, our findings highlight a unique diversity of human ROR\u03b3t\n                    <jats:sup>+<\/jats:sup>\n                    T cells and underscore the potential of ROR\u03b3t antagonism to modulate aberrant type 17 responses.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-07911-6","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:59:44Z","timestamp":1545915584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":280,"title":["ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Koen","family":"Venken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Labadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Decruy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Coudenys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita L.","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Van Gassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-7456","authenticated-orcid":false,"given":"Liesbet","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Harcken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Verheugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Schryvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Varkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Cypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Wittoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Gyselbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-1264","authenticated-orcid":false,"given":"Serge","family":"Van Calenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Saeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Nabozny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"7911_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit, M. et al. The Assessment of Spondylo Arthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25\u201331 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"7911_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/mi.2008.24","volume":"1","author":"P Jacques","year":"2008","unstructured":"Jacques, P. & Elewaut, D. Joint expedition: linking gut inflammation to arthritis. Mucosal Immunol. 1, 364\u2013371 (2008).","journal-title":"Mucosal Immunol."},{"key":"7911_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11926-015-0507-2","volume":"17","author":"K Venken","year":"2015","unstructured":"Venken, K. & Elewaut, D. IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear. Curr. Rheumatol. Rep. 17, 30 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"7911_CR4","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten, D. et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N. Engl. J. Med. 373, 2534\u20132548 (2015).","journal-title":"N. Engl. J. Med."},{"key":"7911_CR5","doi-asserted-by":"crossref","unstructured":"Baeten, D. et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann. Rheumatic Dis. 77, 1295\u20131302 (2018).","DOI":"10.1136\/annrheumdis-2018-213328"},{"key":"7911_CR6","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1053\/j.gastro.2012.07.084","volume":"143","author":"SR Targan","year":"2012","unstructured":"Targan, S. R. et al. A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and efficacy of AMG 827 in subjects with moderate to severe Crohn\u2019s disease. Gastroenterology 143, E26\u2013E26 (2012).","journal-title":"Gastroenterology"},{"key":"7911_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/art.40070","volume":"69","author":"FJ Blanco","year":"2017","unstructured":"Blanco, F. J. et al. Secukinumab in active rheumatoid arthritis: a phase iii randomized, double-blind, active comparator- and placebo-controlled study. Arthritis Rheumatol. 69, 1144\u20131153 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"7911_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2015.08.019","volume":"43","author":"JR Maxwell","year":"2015","unstructured":"Maxwell, J. R. et al. Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation. Immunity 43, 739\u2013750 (2015).","journal-title":"Immunity"},{"key":"7911_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee, J. S. et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43, 727\u2013738 (2015).","journal-title":"Immunity"},{"key":"7911_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ni.2025","volume":"12","author":"GF Sonnenberg","year":"2011","unstructured":"Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383\u2013390 (2011).","journal-title":"Nat. Immunol."},{"key":"7911_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"7911_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2017.02.006","volume":"38","author":"C Zhong","year":"2017","unstructured":"Zhong, C. & Zhu, J. Small-molecule RORgammat antagonists: one stone kills two birds. Trends Immunol. 38, 229\u2013231 (2017).","journal-title":"Trends Immunol."},{"key":"7911_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"7911_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat. Med. 18, 1069\u20131076 (2012).","journal-title":"Nat. Med."},{"key":"7911_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.berh.2016.02.002","volume":"29","author":"K Venken","year":"2015","unstructured":"Venken, K. & Elewaut, D. New immune cells in spondyloarthritis: key players or innocent bystanders? Best. Pract. Res. Clin. Rheumatol. 29, 706\u2013714 (2015).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"7911_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri3328","volume":"12","author":"J Rossjohn","year":"2012","unstructured":"Rossjohn, J., Pellicci, D. G., Patel, O., Gapin, L. & Godfrey, D. I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845\u2013857 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"7911_CR17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ni.2731","volume":"14","author":"YJ Lee","year":"2013","unstructured":"Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. & Hogquist, K. A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146\u20131154 (2013).","journal-title":"Nat. Immunol."},{"key":"7911_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien, Y. H., Meyer, C. & Bonneville, M. gammadelta T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121\u2013155 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"7911_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","volume":"31","author":"B Martin","year":"2009","unstructured":"Martin, B., Hirota, K., Cua, D. J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321\u2013330 (2009).","journal-title":"Immunity"},{"key":"7911_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","volume":"118","author":"N Caccamo","year":"2011","unstructured":"Caccamo, N. et al. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 118, 129\u2013138 (2011).","journal-title":"Blood"},{"key":"7911_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A. 87, 636\u20136 45 (2015).","journal-title":"Cytom. A."},{"key":"7911_CR22","doi-asserted-by":"crossref","unstructured":"Maggi, L. et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 40, 2174\u20132181 (2010).","DOI":"10.1002\/eji.200940257"},{"key":"7911_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.immuni.2012.06.003","volume":"37","author":"JD Haas","year":"2012","unstructured":"Haas, J. D. et al. Development of interleukin-17-producing gammadelta T cells is restricted to a functional embryonic wave. Immunity 37, 48\u201359 (2012).","journal-title":"Immunity"},{"key":"7911_CR24","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/eji.201343759","volume":"43","author":"I Prinz","year":"2013","unstructured":"Prinz, I., Silva-Santos, B. & Pennington, D. J. Functional development of gammadelta T cells. Eur. J. Immunol. 43, 1988\u20131994 (2013).","journal-title":"Eur. J. Immunol."},{"key":"7911_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/icb.2014.94","volume":"93","author":"C Paget","year":"2015","unstructured":"Paget, C. et al. CD3bright signals on gammadelta T cells identify IL-17A-producing Vgamma6Vdelta1+T cells. Immunol. Cell Biol. 93, 198\u2013212 (2015).","journal-title":"Immunol. Cell Biol."},{"key":"7911_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","volume":"29","author":"AK Savage","year":"2008","unstructured":"Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391\u2013403 (2008).","journal-title":"Immunity"},{"key":"7911_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.1641","volume":"9","author":"D Kovalovsky","year":"2008","unstructured":"Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055\u20131064 (2008).","journal-title":"Nat. Immunol."},{"key":"7911_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1084\/jem.20142110","volume":"212","author":"A Rahimpour","year":"2015","unstructured":"Rahimpour, A. et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J. Exp. Med. 212, 1095\u20131108 (2015).","journal-title":"J. Exp. Med."},{"key":"7911_CR29","doi-asserted-by":"publisher","first-page":"12453","DOI":"10.1073\/pnas.0903895106","volume":"106","author":"T Kreslavsky","year":"2009","unstructured":"Kreslavsky, T. et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc. Natl Acad. Sci. USA 106, 12453\u201312458 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7911_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"MG Constantinides","year":"2014","unstructured":"Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397\u2013401 (2014).","journal-title":"Nature"},{"key":"7911_CR31","doi-asserted-by":"publisher","first-page":"e24441","DOI":"10.1371\/journal.pone.0024441","volume":"6","author":"M Eidson","year":"2011","unstructured":"Eidson, M. et al. Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS One 6, e24441 (2011).","journal-title":"PLoS One"},{"key":"7911_CR32","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.4049\/jimmunol.1401093","volume":"194","author":"SP Singh","year":"2015","unstructured":"Singh, S. P. et al. PLZF regulates CCR6 and is critical for the acquisition and maintenance of the Th17 phenotype in human cells. J. Immunol. 194, 4350\u20134361 (2015).","journal-title":"J. Immunol."},{"key":"7911_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni.2490","volume":"14","author":"NR Cohen","year":"2013","unstructured":"Cohen, N. R. et al. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat. Immunol. 14, 90\u201399 (2013).","journal-title":"Nat. Immunol."},{"key":"7911_CR34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4049\/jimmunol.1600643","volume":"197","author":"YJ Lee","year":"2016","unstructured":"Lee, Y. J. et al. Lineage-specific effector signatures of invariant NKT cells are shared amongst gammadelta T, innate lymphoid, and Th cells. J. Immunol. 197, 1460\u20131470 (2016).","journal-title":"J. Immunol."},{"key":"7911_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ni.3047","volume":"16","author":"L Lynch","year":"2015","unstructured":"Lynch, L. et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 16, 85\u201395 (2015).","journal-title":"Nat. Immunol."},{"key":"7911_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","volume":"43","author":"YJ Lee","year":"2015","unstructured":"Lee, Y. J. et al. Tissue-specific distribution of iNKT cells impacts their cytokine response. Immunity 43, 566\u2013578 (2015).","journal-title":"Immunity"},{"key":"7911_CR37","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20102630","volume":"208","author":"SY Thomas","year":"2011","unstructured":"Thomas, S. Y. et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 208, 1179\u20131188 (2011).","journal-title":"J. Exp. Med."},{"key":"7911_CR38","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.4049\/jimmunol.1500939","volume":"195","author":"Y Lu","year":"2015","unstructured":"Lu, Y., Cao, X., Zhang, X. & Kovalovsky, D. PLZF controls the development of fetal-derived IL-17+ Vgamma6+ gammadelta T cells. J. Immunol. 195, 4273\u20134281 (2015).","journal-title":"J. Immunol."},{"key":"7911_CR39","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.4049\/jimmunol.0900732","volume":"182","author":"A Awasthi","year":"2009","unstructured":"Awasthi, A. et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904\u20135908 (2009).","journal-title":"J. Immunol."},{"key":"7911_CR40","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.4049\/jimmunol.1003043","volume":"186","author":"L Moreira-Teixeira","year":"2011","unstructured":"Moreira-Teixeira, L. et al. Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. J. Immunol. 186, 5758\u20135765 (2011).","journal-title":"J. Immunol."},{"key":"7911_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","volume":"45","author":"M Guilliams","year":"2016","unstructured":"Guilliams, M. et al. Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species. Immunity 45, 669\u2013684 (2016).","journal-title":"Immunity"},{"key":"7911_CR42","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","volume":"75","author":"E Gracey","year":"2016","unstructured":"Gracey, E. et al. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann. Rheum. Dis. 75, 2124\u20132132 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"7911_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739\u20131747 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"7911_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01771-2","volume":"8","author":"MH Al-Mossawi","year":"2017","unstructured":"Al-Mossawi, M. H. et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat. Commun. 8, 1510 (2017).","journal-title":"Nat. Commun."},{"key":"7911_CR45","doi-asserted-by":"publisher","first-page":"6145810","DOI":"10.1155\/2016\/6145810","volume":"2016","author":"R Kugyelka","year":"2016","unstructured":"Kugyelka, R. et al. Enigma of IL-17 and Th17 cells in rheumatoid arthritis and in autoimmune animal models of arthritis. Mediat. Inflamm. 2016, 6145810 (2016).","journal-title":"Mediat. Inflamm."},{"key":"7911_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So, A. K. & Martinon, F. Inflammation in gout: mechanisms and therapeutic targets. Nat. Rev. Rheumatol. 13, 639\u2013647 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7911_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","volume":"43","author":"MS Denison","year":"2003","unstructured":"Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309\u2013334 (2003).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"7911_CR48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","volume":"496","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518\u2013522 (2013).","journal-title":"Nature"},{"key":"7911_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513\u2013517 (2013).","journal-title":"Nature"},{"key":"7911_CR50","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.immuni.2013.01.010","volume":"38","author":"N Malhotra","year":"2013","unstructured":"Malhotra, N. et al. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38, 681\u2013693 (2013).","journal-title":"Immunity"},{"key":"7911_CR51","doi-asserted-by":"publisher","first-page":"12520","DOI":"10.1073\/pnas.1607136113","volume":"113","author":"C Peters","year":"2016","unstructured":"Peters, C., Hasler, R., Wesch, D. & Kabelitz, D. Human Vdelta2 T cells are a major source of interleukin-9. Proc. Natl Acad. Sci. USA 113, 12520\u201312525 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7911_CR52","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1002\/art.10605","volume":"46","author":"S Kollnberger","year":"2002","unstructured":"Kollnberger, S. et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum. 46, 2972\u20132982 (2002).","journal-title":"Arthritis Rheum."},{"key":"7911_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness, P. Hla-B27. Annu. Rev. Immunol. 33, 29\u201348 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"7911_CR54","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3260","volume":"19","author":"G Schett","year":"2013","unstructured":"Schett, G., Elewaut, D., McInnes, I. B., Dayer, J. M. & Neurath, M. F. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 19, 822\u2013824 (2013).","journal-title":"Nat. Med."},{"key":"7911_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature09978","volume":"472","author":"JR Huh","year":"2011","unstructured":"Huh, J. R. et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 472, 486\u2013490 (2011).","journal-title":"Nature"},{"key":"7911_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature10075","volume":"472","author":"LA Solt","year":"2011","unstructured":"Solt, L. A. et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472, 491\u2013494 (2011).","journal-title":"Nature"},{"key":"7911_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","volume":"40","author":"S Xiao","year":"2014","unstructured":"Xiao, S. et al. Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity 40, 477\u2013489 (2014).","journal-title":"Immunity"},{"key":"7911_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9833","volume":"6","author":"M Scheepstra","year":"2015","unstructured":"Scheepstra, M. et al. Identification of an allosteric binding site for RORgammat inhibition. Nat. Commun. 6, 8833 (2015).","journal-title":"Nat. Commun."},{"key":"7911_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep37977","volume":"6","author":"X Xue","year":"2016","unstructured":"Xue, X. et al. Pharmacologic modulation of RORgammat translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis. Sci. Rep. 6, 37977 (2016).","journal-title":"Sci. Rep."},{"key":"7911_CR60","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jaci.2015.09.048","volume":"137","author":"J de Wit","year":"2016","unstructured":"de Wit, J. et al. RORgammat inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease. J. Allergy Clin. Immunol. 137, 960\u2013963 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"7911_CR61","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/art.38272","volume":"66","author":"MR Chang","year":"2014","unstructured":"Chang, M. R., Lyda, B., Kamenecka, T. M. & Griffin, P. R. Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor gamma is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol. 66, 579\u2013588 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"7911_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nm.4046","volume":"22","author":"DR Withers","year":"2016","unstructured":"Withers, D. R. et al. Transient inhibition of ROR-gammat therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat. Med. 22, 319\u2013323 (2016).","journal-title":"Nat. Med."},{"key":"7911_CR63","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.celrep.2016.11.073","volume":"17","author":"Y Guo","year":"2016","unstructured":"Guo, Y. et al. Inhibition of ROR gamma T Skews TCR alpha gene rearrangement and limits T cell repertoire diversity. Cell Rep. 17, 3206\u20133218 (2016).","journal-title":"Cell Rep."},{"key":"7911_CR64","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.aaa4282","volume":"349","author":"S Okada","year":"2015","unstructured":"Okada, S. et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349, 606\u2013613 (2015).","journal-title":"Science"},{"key":"7911_CR65","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372\u2013385 (2013).","journal-title":"Immunity"},{"key":"7911_CR66","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.immuni.2013.08.002","volume":"39","author":"J Qiu","year":"2013","unstructured":"Qiu, J. et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39, 386\u2013399 (2013).","journal-title":"Immunity"},{"key":"7911_CR67","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3389\/fimmu.2018.01489","volume":"9","author":"C Mortier","year":"2018","unstructured":"Mortier, C., Govindarajan, S., Venken, K. & Elewaut, D. It takes \u201cGuts\u201d to cause joint inflammation: role of innate-like T cells. Front. Immunol. 9, 1489 (2018).","journal-title":"Front. Immunol."},{"key":"7911_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05095-7","volume":"9","author":"M Zhao","year":"2018","unstructured":"Zhao, M. et al. Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. Nat. Commun. 9, 2627 (2018).","journal-title":"Nat. Commun."},{"key":"7911_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ni.1969","volume":"12","author":"V Lazarevic","year":"2011","unstructured":"Lazarevic, V. et al. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12, 96\u2013104 (2011).","journal-title":"Nat. Immunol."},{"key":"7911_CR70","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1136\/annrheumdis-2013-203881","volume":"73","author":"L Melis","year":"2014","unstructured":"Melis, L., Van, P. L., Pircher, H., Venken, K. & Elewaut, D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-alpha production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann. Rheum. Dis. 73, 1223\u20131231 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"7911_CR71","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.4049\/jimmunol.1300562","volume":"191","author":"K Venken","year":"2013","unstructured":"Venken, K. et al. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells. J. Immunol. 191, 2174\u20132183 (2013).","journal-title":"J. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07911-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07911-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07911-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T13:30:28Z","timestamp":1671197428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07911-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["7911"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07911-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734749124.793558443","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.734749124.793564718","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.734749124.793573535","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"24 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}